Literature DB >> 10730770

Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique.

M R Thissen1, C A Schroeter, H A Neumann.   

Abstract

The incidence of basal cell carcinomas (BCCs) is still increasing, and there is a demand for an easy, effective and selective non-invasive treatment such as topical photodynamic therapy (PDT). Twenty-three patients with 24 nodular BCCs were treated once with delta-aminolaevulinic acid (delta-ALA) PDT (100 mW cm(-2), 120 J/cm2) 3 weeks after prior debulking of the BCCs. Three months after PDT, all lesions were surgically excised and histopathologically evaluated for residual tumour. Twenty-two (92%) of the 24 nodular BCCs showed a complete response on clinical and histopathological examination. PDT for superficially abraded nodular BCCs with topically applied delta-ALA and the VersaLight as light source is an easy, effective and safe therapy, with excellent cosmetic results and no serious side-effects, in cases where non-surgical treatment of BCCs is indicated.

Entities:  

Mesh:

Year:  2000        PMID: 10730770     DOI: 10.1046/j.1365-2133.2000.03404.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

Review 1.  [Photodynamic therapy of cutaneous epithelial malignancies. An evidence-based review].

Authors:  A Sidoroff
Journal:  Hautarzt       Date:  2007-07       Impact factor: 0.751

Review 2.  Recent advances in the prevention and treatment of skin cancer using photodynamic therapy.

Authors:  Baozhong Zhao; Yu-Ying He
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

3.  Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models.

Authors:  Kishore Rollakanti; Sanjay Anand; Edward V Maytin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-02

4.  The Immunogenetic Aspects of Photodynamic Therapy.

Authors:  Chaw-Ning Lee; Tak-Wah Wong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  [Topical therapy of squamous cell carcinoma].

Authors:  U R Hengge
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

Review 6.  Pharmacological treatments for basal cell carcinoma.

Authors:  Seongmu Lee; Dinesh Selva; Shyamala C Huilgol; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.

Authors:  Edward V Maytin; Urvashi Kaw; Muneeb Ilyas; Judith A Mack; Bo Hu
Journal:  Photodiagnosis Photodyn Ther       Date:  2018-02-19       Impact factor: 3.631

8.  No-needle jet intradermal aminolevulinic Acid photodynamic therapy for recurrent nodular Basal cell carcinoma of the nose: a case report.

Authors:  Daniel Barolet; Annie Boucher
Journal:  J Skin Cancer       Date:  2010-10-18

9.  Pre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy.

Authors:  Eidi Christensen; Cato Mørk; Olav Andreas Foss
Journal:  J Skin Cancer       Date:  2011-11-15

Review 10.  Photodynamic therapy in the treatment of basal cell carcinoma.

Authors:  C Matei; M Tampa; T Poteca; G Panea-Paunica; S R Georgescu; R M Ion; S M Popescu; C Giurcaneanu
Journal:  J Med Life       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.